Contraceptive Innovation Index

This tool builds upon the United States Agency for International Development's (USAID) Global Health Innovation Index, with adaptations made to reflect the complexities of contraceptive markets. The Contraceptive Innovation Index uses four core criteria to evaluate the potential for impact of contraceptive technologies: user demand and impact, system factors and sustainability, supplier capacity and progression to scale. The tool assesses the potential for scale and impact by evaluating innovations according to these four core criteria. Innovations are scored with a color scale of red, yellow, and green, to indicate the strength and quality of evidence available. The Contraceptive Innovation Index was developed to support decisions about whether to launch and/or scale new contraceptive technologies. The Global Health Innovation Index, upon which the Contraceptive Innovation Index is based, was designed to offer a strategic approach to helping identify promising, ready-to-launch innovations. The Index evaluates innovations according to four core criteria: health impact, demand and sustainability, organizational and/or partner capacity, and progression to scale. Innovations are scored with a color scale of red, yellow, and green, to indicate the strength and quality of evidence available. The Contraceptive Innovation Index can be applied by a variety of stakeholders, including Ministries of Health (MOHs), donors, implementers, and innovators themselves. Evaluators who use the tool are encouraged to draw on an assortment of data sources and methodologies to avoid bias. The tool is not intended to be a report card for whether to launch or scale a particular health innovation, but rather a helpful tool to aid ongoing discussions and decision-making around scale-up. The Contraceptive Innovation Index was adapted from the Global Health Innovation Index through a collaborative effort between USAID's Center for Innovation and Impact (CII) and Office of Population and Reproductive Health (PRH), along with the USAID-funded Expanding Effective Contraceptive Options (EECO) project. The adaptation process involved seeking input and feedback from a range of stakeholders, including MOHs, donors, implementers, and innovators. The Contraceptive Innovation Index is intended to support the introduction and scale-up of contraceptive technologies that have the greatest potential for impact, both in the short and long term. The tool is designed to help stakeholders identify which contraceptive technologies have the greatest potential for impact, and where additional data or investment would be most useful before supporting or introducing a given innovation.